Research New Obinutuzumab Study Published Obinutuzumab (Gazyva) improved overall response and had acceptable toxicity compared with rituximab (Rituxan) in patients…adminAugust 25, 2015
Research Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation Brentuximab Vedotin is Effective as Salvage Therapy in Patients with Relapsed/Refractory Hodgkin Lymphoma Prior to…adminAugust 17, 2015
Research BC Cancer Agency Researchers Develop Improved Prognostic Test for Follicular Lymphoma Mutation patterns in seven genes may help predict outcomes for individuals with follicular lymphoma (more…)adminAugust 10, 2015
NewsResearch Health Canada Approves ibrutinib for Mantle Cell Lymphoma Health Canada has issued a Notice of Compliance with Conditions (NOC/c) for ibrutinib (Imbruvica®), a…adminJuly 31, 2015
News Matt’s Head-Shaving Fundraiser The head-shaving event at their house raised $1,800 with over 35 people attending and 16…adminJuly 30, 2015
News Lymphoma Canada 2015 Research Fellowship Award Lymphoma Canada is pleased to award its 2015 Research Fellowship to Dr. Kerry Savage, a…adminJuly 30, 2015
Press Releases take it to the mat Press Release July 2015 TORONTO, July 7, 2015—take it to the mat, The Great Yoga & Wellness Revolution, in…adminJuly 23, 2015
NewsResearch Specific subtype of diffuse large B-cell lymphoma more likely to respond to ibrutinib A recent study shows that patients with a specific molecular subtype of diffuse large B-cell…adminJuly 21, 2015
NewsResearch Aggressive lymphoma linked to disruption in cell energy production A new study finds evidence that a genetic enzyme deficiency that affects the ability of…adminJuly 20, 2015
News Newmarket Fundraiser in Support of Lymphoma Canada On June 12, 2015, Hungry Brew Hops hosted a tap-takeover event where they presented Lymphoma…adminJuly 2, 2015